No Data
No Data
Insiders Were the Key Beneficiaries as Tuoxin Pharmaceutical Group Co.,Ltd.'s (SZSE:301089) Market Cap Rises to CN¥4.4b
Tuoxin Pharmaceutical (301089.SZ): products such as Tetraacetylribose and Nicotinamide Riboside (NR) can be used as intermediates for the production of downstream NMN.
On August 14th, Bio-Thera Solutions (301089.SZ) stated on the investor platform that its product, tetraacetyl ribose and nicotinamide riboside (NR), can serve as intermediates for downstream production of NMN.
The products of Tuoxin Pharmaceutical (301089.SZ) are mainly used in the fields of antiviral, anti-tumor, and central nervous system drugs.
On August 14th, Gelunhui reported that Tuoxin Pharmaceuticals (301089.SZ) stated on an investor interaction platform that the company's products are mainly used in the fields of antiviral, anti-tumor, and neurological system medications.
Investor Optimism Abounds Tuoxin Pharmaceutical Group Co.,Ltd. (SZSE:301089) But Growth Is Lacking
Tuoxin Pharmaceutical (301089.SZ) plans to distribute 2.5 yuan for 10 shares to be deducted from interest on May 23
Tuoxin Pharmaceutical (301089.SZ) announced that the company's 2023 equity distribution plan: 2.5 for every 10 shares...
Tuoxin Pharmaceutical (301089.SZ): Actively carry out research on the application of synthetic biology-related technologies in the field of nucleosides and nucleotide products
On May 8, Gelonghui | Tuoxin Pharmaceutical (301089.SZ) announced abnormal stock trading fluctuations. Recently, the company noticed that the Internet and some media published reports on “synthetic biology.” Guided by the principles of systems biology and engineering, synthetic biology takes genomic and biochemical molecular synthesis as the core technology. Through biochemistry, biophysics, and bioinformatics, it continuously designs, transforms, and reshapes biomolecules, biological components, and biological differentiation processes, laying a solid foundation for constructing bioactive biological elements, systems, and artificial cells or organisms. In the field of healthcare, synthesis
No Data